CoChat
Sign Up
Cited by 550

The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.

The reporting of studies conducted using observational routinely collected health data statement for pharmacoepidemiology (RECORD-PE).

Langan, Sinéad M, Schmidt, Sigrún AJ, Wing, Kevin, Ehrenstein, Vera, Nicholls, Stuart G, Filion, Kristian B, Klungel, Olaf, Petersen, Irene, Sorensen, Henrik T, Dixon, William G, Guttmann, Astrid, Harron, Katie, Hemkens, Lars G, Moher, David, Schneeweiss, Sebastian, Smeeth, Liam, Sturkenboom, Miriam, von Elm, Erik, Wang, Shirley V, Benchimol, Eric I·2018·BMJ
DOI 10.1136/bmj.k3532PMC PMC6234471
Open this paper in CoChat — free account

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/bmj.k3532

Cites

14 of 14 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Example of a diagram showing a typical timeline for a patient. *Liver injury could occur at any point during observation period. Adapted from Douglas et al29 with permission
Fig 1 Example of a diagram showing a typical timeline for a patient. *Liver injury could occur at any point during observation period. Adapted from Douglas et al29 with permissionCC BY · PubMed Central
Fig 2 Example of a diagram illustrating cohort entry criteria, exposure assessment, and censoring events including time periods. RA=rheumatoid arthritis; TCZ=tocilizumab; TNFi=tumour necrosis factor inhibitors; Dx=diagnosis; Rx=prescription. Adapted from Kim et al30 with permission
Fig 2 Example of a diagram illustrating cohort entry criteria, exposure assessment, and censoring events including time periods. RA=rheumatoid arthritis; TCZ=tocilizumab; TNFi=tumour necrosis factor inhibitors; Dx=diagnosis; Rx=prescription. Adapted from Kim et al30 with permissionCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 70

  1. Spasoff, 1999, Epidemiologic methods for health policy.
  2. 10.1136/bmjopen-2016-011523 · DOI
  3. 10.1111/joim.12437 · DOI
  4. 10.9778/cmajo.20150036 · DOI
  5. 10.1016/S0140-6736(15)00307-4 · DOI · Paper page
  6. Canadian Institutes of Health Research, 2011, Canada’s strategy for patient-oriented research. Improving health outcomes through evidence-informed care.
  7. 10.1177/009885881303900401 · DOI
  8. 10.1377/hlthaff.2014.0048 · DOI · Paper page
  9. 10.1016/j.jclinepi.2016.06.005 · DOI
  10. 10.1002/cpt.329 · DOI
  11. 10.1016/S0140-6736(08)60505-X · DOI · Paper page
  12. 10.1097/EDE.0b013e3181577654 · DOI · Paper page
  13. Strom, 2005, Pharmacoepidemiology., 3
  14. Dreyer, 2010, GRACE principles: recognizing high-quality observational studies of comparative effectiveness, Am J Manag Care, 16, 467
  15. 10.1002/pds.4295 · DOI
  16. 10.1093/aje/kwv254 · DOI · Paper page
  17. 10.1001/jamainternmed.2016.5954 · DOI
  18. 10.1542/peds.2017-0441 · DOI
  19. 10.1002/pds.4203 · DOI
  20. 10.1136/bmj.f1936 · DOI · Paper page
  21. 10.1002/art.40084 · DOI
  22. 10.1093/qjmed/93.2.105 · DOI · Paper page
  23. 10.1111/bcp.13208 · DOI
  24. 10.1002/pds.3825 · DOI
  25. 10.1001/jama.2017.3413 · DOI · Paper page
  26. 10.1136/bmjopen-2013-003424 · DOI
  27. 10.1136/bmj.39553.670231.25 · DOI
  28. 10.1002/pds.4440 · DOI
  29. 10.1093/aje/kwv225 · DOI · Paper page
  30. 10.1007/s40264-017-0525-2 · DOI
  31. 10.1136/ard.2009.125526 · DOI
  32. 10.1016/0002-9343(80)90363-0 · DOI · Paper page
  33. 10.1136/ard.2009.118935 · DOI
  34. 10.1111/bcpt.12946 · DOI
  35. 10.1002/sim.4343 · DOI
  36. Moride, 1994, Evidence of the depletion of susceptibles effect in non-experimental pharmacoepidemiologic research [correction in: J Clin Epidemiol 2004;57:111], J Clin Epidemiol, 47, 731
  37. 10.1016/0895-4356(89)90116-9 · DOI
  38. Movahedi, 2016, Risk of incident diabetes mellitus associated with the dosage and duration of oral glucocorticoid therapy in patients with rheumatoid arthritis, Arthritis Rheumatol, 68, 1089, 10.1002/art.39537 · DOI
  39. 10.1002/sim.4780020222 · DOI
  40. 10.1056/NEJMoa1506115 · DOI · Paper page
  41. Xue, 2013, Design and methods of a postmarketing pharmacoepidemiology study assessing long-term safety of Prolia (denosumab) for the treatment of postmenopausal osteoporosis, Pharmacoepidemiol Drug Saf, 22, 1107, 10.1002/pds.3477 · DOI
  42. 10.1136/bmj.h6926 · DOI
  43. 10.1161/STROKEAHA.110.579375 · DOI
  44. 10.1136/bmj.i4919 · DOI · Paper page
  45. 10.1016/j.jclinepi.2004.10.012 · DOI
  46. 10.1111/resp.12312 · DOI
  47. 10.1093/aje/kwi106 · DOI
  48. 10.1093/aje/155.11.1045 · DOI
  49. 10.1002/pds.4216 · DOI
  50. 10.1186/s12874-016-0278-0 · DOI
  51. 10.1136/bmj.i4515 · DOI · Paper page
  52. 10.1136/bmj.a1069 · DOI
  53. 10.1002/sim.2302 · DOI · Paper page
  54. Cadarette, 2017, Control yourself: guidance for the application and reporting of self-controlled study designs in pharmacoepidemiology, Pharmacoepidemiol Drug Saf, 26, 3
  55. 10.1093/aje/kwn135 · DOI
  56. 10.1371/journal.pone.0027897 · DOI
  57. 10.1136/jamia.2009.002477 · DOI
  58. 10.1007/s00125-017-4312-5 · DOI
  59. 10.1002/phar.1367 · DOI
  60. 10.2147/CLEP.S59156 · DOI
  61. 10.1159/000315387 · DOI
  62. 10.1007/s40264-017-0581-7 · DOI
  63. 10.1002/pds.3923 · DOI
  64. 10.1056/NEJMoa0707571 · DOI
  65. 10.1007/978-3-319-33525-4_15 · DOI
  66. 10.1186/s12916-016-0587-5 · DOI
  67. 10.1136/bmj.g5511 · DOI
  68. 10.1016/j.jclinepi.2017.09.017 · DOI
  69. 10.1186/s13063-017-2394-5 · DOI
  70. 10.1016/S0140-6736(13)62228-X · DOI · Paper page

Cited by

Sorted by citations

See all 550

Metadata

Authors
Langan, S. M., Schmidt, S. A., Wing, K., Ehrenstein, V., Nicholls, S. G., Filion, K. B., Klungel, O., Petersen, I., Sorensen, H. T., Dixon, W. G., Guttmann, A., Harron, K., Hemkens, L. G., Moher, D., Schneeweiss, S., Smeeth, L., Sturkenboom, M., von Elm, E., Wang, S. V., & Benchimol, E. I.
Venue
BMJ
Publisher
BMJ
Published
2018-11-14
Pages
k3532
ISSN
  • 0959-8138
  • 1756-1833
DOI
10.1136/bmj.k3532
PMC
PMC6234471
Cited by
550
References
14
Language
en
Licence
www.bmj.com/company/legal-information/terms-conditions/legal-information/tdm-licencepolicy (tdm)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review